HHS awarding $87 million for IT enhancements at health centers

More than 1,300 health centers around the U.S. and in several overseas territories will receive a total of $87 million in federal grants to purchase or upgrade IT systems.

“Health centers across the country are instrumental in providing high-quality, comprehensive primary health care to millions of people,” HHS Secretary Sylvia Burwell said in a statement. “This investment will help unlock healthcare data and put it to work, improving health outcomes and building a better health care system for the American people.”

The HHS release said the grants, the first of their kind awarded since 2009,  will support technology enhancements to “accelerate health centers’ transition to value-based models of care” and improve data sharing. Any electronic health record systems purchased or upgraded with the funding have to use technology certified by the Office of the National Coordinator for Health IT.

The awards are spread out among facilities in all 50 states, most of them below $100,000. The largest single grant is $286,000 going to Altamed Health Services in Los Angeles. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.